Archives 2016

October 27, 2016

Velicept Therapeutics, INC. Names CLARENCE YOUNG, M.D., Chief Medical Officer

October 05, 2016

Velicept Therapeutics Announces FDA Acceptance of IND Application of Novel, Once-daily Formulation of Solabegron for the treatment of Overactive Bladder

March 23, 2016

FDA Approved Cinqair (reslizumab) To Treat Severe Asthma

Please reload